Your browser doesn't support javascript.
loading
Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.
Niu, Ho-Shan; Ku, Po-Ming; Niu, Chiang-Shan; Cheng, Juei-Tang; Lee, Kung-Shing.
Afiliação
  • Niu HS; Department of Nursing, Tzu Chi College of Technology, Hualien City, Taiwan.
  • Ku PM; Department of Cardiology, Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan ; Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan.
  • Niu CS; Department of Nursing, Tzu Chi College of Technology, Hualien City, Taiwan.
  • Cheng JT; Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan ; Institute of Medical Sciences, Chang Jung Christian University, Guiren, Tainan City, Taiwan.
  • Lee KS; Department of Surgery, Division of Neurosurgery, Pingtung Hospital, Kaohsiung Medical University, Kaohsiung City, Taiwan ; Department of Surgery, Kaohsiung Medical University, Kaohsiung City, Taiwan ; School of Medicine, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung City, Taiwa
Drug Des Devel Ther ; 9: 5625-32, 2015.
Article em En | MEDLINE | ID: mdl-26508837

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / PPAR alfa / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Descoberta de Drogas / Hipoglicemiantes Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / PPAR alfa / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Descoberta de Drogas / Hipoglicemiantes Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article